Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_03433
Species: Mus musculus
Position : chr15:63255515-63256347
Year: 2019
Title: GATA3-Controlled Nucleosome Eviction Drives MYC Enhancer Activity in T-cell Development and Leukemia.
Genome Build: mm10
Enhancer Type: Enhancer
Condition: Disease
Disease Name: T-cell acute lymphoblastic leukemia
PMID:  31519704
MONDO: MONDO:0004963
Tissue: thymus
Tissue Ontology ID: UBERON:0002370
Cell Source: N-Me GATA-site mutant mouse DN3 thymocytes
Cell Type: double negative thymocyte
Cell Ontology ID: CL:0002489
Experiment Type: Endogenous TF-site perturbation; enhancer accessibility assay; enhancer-promoter interaction assay
High Throughput Method: ATAC-seq; ChIP-seq; 4C-seq
Low Throughput Method: Endogenous GATA-site mutation; flow cytometry; ChIP-qPCR; DNA FISH; nucleosome occupancy analysis; RT-qPCR
About Target Gene
Target gene : Myc
About TF
TF name : Gata3
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Gata3 C-MYB transcription factor network pid 87
Gata3 Calcineurin-regulated NFAT-dependent transcription in lymphocytes pid 50
Gata3 Factors involved in megakaryocyte development and platelet production reactome 111
Gata3 Glucocorticoid receptor regulatory network pid 85
Gata3 IL27-mediated signaling events pid 26
Gata3 Notch signaling pathway pid 58
Gata3 Regulation of nuclear SMAD2/3 signaling pid 82
Gata3 Hs_Endochondral_Ossification_WP474_87977 wikipathways 43
Gata3 Hs_White_fat_cell_differentiation_WP3946_90940 wikipathways 30
Enhancer Associated Network
Overlapping Enhancers (mm10) 2 found
Enhancer ID Position Tissue Cell Disease
E_01399 chr15:63254341-63256341 thymus T lymphoblast T-cell acute lymphoblastic leukemia
E_01434 chr15:63254341-63256341 blood / hematopoietic system T cell acute lymphoblastic leukemia
Expression of Target Genes for the Enhancer